News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cabell Christopher
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/22/2023 |
4
| Cabell Christopher (CMO & Head of R&D) has filed a Form 4 on Zura Bio Ltd|
Txns:
| Granted 162,060 shares
@ $0 |
|
| 03/21/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/30/2023 |
4
| Cabell Christopher (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 1,700 options to buy
@ $3.99, valued at
$6.8k
|
|
| 01/31/2022 |
4
| Cabell Christopher (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 22,100 options to buy
@ $0.3701, valued at
$8.2k
|
|
| 02/01/2021 |
4
| Cabell Christopher (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.47, valued at
$22.1k
|
|
| 11/30/2020 |
4
| Cabell Christopher (EVP, Head of R&D, and CMO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,099 shares
@ $65.5, valued at
$72k
Exercised 2,500 options to buy
@ $0 |
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
3
| Cabell Christopher (Director) has filed a Form 3 on Pulmatrix, Inc. |
| 06/25/2020 |
4
| Cabell Christopher (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.95, valued at
$58.5k
|
|
| 06/16/2020 |
4
| Cabell Christopher (EVP, Head of R&D, and CMO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $61.31, valued at
$1.2M
|
|
| 06/16/2020 |
3
| Cabell Christopher (EVP, Head of R&D, and CMO) has filed a Form 3 on ARENA PHARMACEUTICALS INC |
|
|